Martinez-Calle M, Courbon G, Hunt-Tobey B, Francis C, Spindler J, Wang X
J Clin Invest. 2023; 133(11).
PMID: 37079387
PMC: 10231994.
DOI: 10.1172/JCI159928.
Ramatchandirin B, Pearah A, He L
Life (Basel). 2023; 13(2).
PMID: 36836874
PMC: 9962321.
DOI: 10.3390/life13020515.
Sheppard S, Barrett B, Muraresku C, McKnight H, De Leon D, Lord K
Am J Med Genet A. 2020; 185(2):566-570.
PMID: 33251707
PMC: 8132289.
DOI: 10.1002/ajmg.a.61978.
Dubois V, Staels B, Lefebvre P, Verzi M, Eeckhoute J
Cells. 2020; 9(10).
PMID: 32998360
PMC: 7600215.
DOI: 10.3390/cells9102185.
Wang Z, Li Y, Wu D, Yu S, Wang Y, Chan F
Oncogene. 2019; 39(7):1572-1589.
PMID: 31695151
PMC: 7018660.
DOI: 10.1038/s41388-019-1080-3.
The Nuclear Receptor Field: A Historical Overview and Future Challenges.
Mazaira G, Zgajnar N, Lotufo C, Daneri-Becerra C, Sivils J, Soto O
Nucl Receptor Res. 2018; 5.
PMID: 30148160
PMC: 6108593.
DOI: 10.11131/2018/101320.
Identification of target genes in cardiomyopathy with fibrosis and cardiac remodeling.
Zhao J, Lv T, Quan J, Zhao W, Song J, Li Z
J Biomed Sci. 2018; 25(1):63.
PMID: 30115125
PMC: 6094872.
DOI: 10.1186/s12929-018-0459-8.
Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations.
Tung J, Boodhansingh K, Stanley C, De Leon D
Pediatr Diabetes. 2018; 19(5):910-916.
PMID: 29493090
PMC: 6030428.
DOI: 10.1111/pedi.12655.
Differential Effects of Hepatocyte Nuclear Factor 4α Isoforms on Tumor Growth and T-Cell Factor 4/AP-1 Interactions in Human Colorectal Cancer Cells.
Vuong L, Chellappa K, Dhahbi J, Deans J, Fang B, Bolotin E
Mol Cell Biol. 2015; 35(20):3471-90.
PMID: 26240283
PMC: 4573706.
DOI: 10.1128/MCB.00030-15.
The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype.
Hamilton A, Bingham C, McDonald T, Cook P, Caswell R, Weedon M
J Med Genet. 2013; 51(3):165-9.
PMID: 24285859
PMC: 3932761.
DOI: 10.1136/jmedgenet-2013-102066.
Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes.
Flannick J, Beer N, Bick A, Agarwala V, Molnes J, Gupta N
Nat Genet. 2013; 45(11):1380-5.
PMID: 24097065
PMC: 4051627.
DOI: 10.1038/ng.2794.
The orphan nuclear receptors at their 25-year reunion.
Mullican S, DiSpirito J, Lazar M
J Mol Endocrinol. 2013; 51(3):T115-40.
PMID: 24096517
PMC: 3845022.
DOI: 10.1530/JME-13-0212.
Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.
Ince I, Knibbe C, Danhof M, de Wildt S
Clin Pharmacokinet. 2013; 52(5):333-45.
PMID: 23463352
DOI: 10.1007/s40262-013-0041-1.
Network insights into the genes regulated by hepatocyte nuclear factor 4 in response to drug induced perturbations: a review.
Azmi A, Bao G, Gao J, Mohammad R, Sarkar F
Curr Drug Discov Technol. 2012; 10(2):147-54.
PMID: 23237677
PMC: 3820112.
DOI: 10.2174/1570163811310020007.
Overexpression of hepatocyte nuclear factor-4α initiates cell cycle entry, but is not sufficient to promote β-cell expansion in human islets.
Rieck S, Zhang J, Li Z, Liu C, Naji A, Takane K
Mol Endocrinol. 2012; 26(9):1590-602.
PMID: 22798294
PMC: 3434530.
DOI: 10.1210/me.2012-1019.
Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors.
Fang B, Mane-Padros D, Bolotin E, Jiang T, Sladek F
Nucleic Acids Res. 2012; 40(12):5343-56.
PMID: 22383578
PMC: 3384313.
DOI: 10.1093/nar/gks190.
Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.
Demirkan A, Van Duijn C, Ugocsai P, Isaacs A, Pramstaller P, Liebisch G
PLoS Genet. 2012; 8(2):e1002490.
PMID: 22359512
PMC: 3280968.
DOI: 10.1371/journal.pgen.1002490.
Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations.
Azmi A, Wang Z, Philip P, Mohammad R, Sarkar F
Mol Cancer Ther. 2010; 9(12):3137-44.
PMID: 21041384
PMC: 3058926.
DOI: 10.1158/1535-7163.MCT-10-0642.
Orphan nuclear receptors as targets for drug development.
Mukherjee S, Mani S
Pharm Res. 2010; 27(8):1439-68.
PMID: 20372994
PMC: 3518931.
DOI: 10.1007/s11095-010-0117-7.
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.
Ellard S, Bellanne-Chantelot C, Hattersley A
Diabetologia. 2008; 51(4):546-53.
PMID: 18297260
PMC: 2270360.
DOI: 10.1007/s00125-008-0942-y.